Cerezyme®

People with Gaucher disease type 1 may not have enough of an enzyme called acid beta-glucocerebrosidase (pronounced gloo-ko-ser-e-bro-sydaze) that breaks down a fatty substance called glucosylceramide (gloo-ko-sil-sara-mide), or GL-1. This may cause a build-up of GL-1 in key organs such as the spleen and liver, as well as in the bones, leading to the signs and symptoms of Gaucher disease type 1. Cerezyme® is a modified form of the enzyme glucocerebrosidase that reduces the build-up of GL-1 in the body.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Cerezyme® Referral Form

MANUFACTURER:

Genzyme Corporation

CLASS:
Enzyme Replacement Therapy (ERT)
WHAT IT TREATS:
PRESCRIBED BY:

Various, including Gaucher Specialists

HOW ADMINISTERED:
IV Infusion
FREQUENCY:

Administered from three times a week to once every two weeks, based upon disease severity.

Length of infusion:
Generally one to two hours. In some cases, more than two hours.